Cardiovascular Endocrinology

A combination of conditions that together increase the risk of Cardiovascular Disease (CVD). Increase in worldwide prevalence of obesity-associated diabetes, dyslipidemia and hypertension makes it imperative that endocrinologists, cardiologists and others have a forum for new treatment and therapeutic developments. Patients with diabetes are at increased risk of developing a number of serious microvascular and macrovascular complications. Across all ages, the relative risk of developing cardiovascular disease (CVD) is ∼2 for patients with diabetes compared with the general population and CVD contributes significantly to the increased, albeit decreasing over time, mortality rate. Still, CVD accounts for up to 50% of deaths in patients with diabetes. The American Heart Association (AHA) predicts that by 2030, 40.5% of the US population will likely have some form of a CVD, and that the direct cost of treating CVDs will triple from $273 billion in 2010 to $818 billion in 2030; with indirect costs expected to increase from $172 billion to $276 billion in the same time period. These statistics are significant because Americans are developing diabetes and CVD at much younger ages than ever, due to overweight or obesity. Metabolic syndrome doubles the risk of CVD and quintuples the diabetes risk. Risk is especially high in men older than age 45 and women older than age 55.

    Related Conference of Cardiovascular Endocrinology

    September 20-21, 2019

    15th World Congress on Endocrinology & Diabetes

    | Prague, Czech Republic
    September 20-21, 2019 |

    Euro Diabetes Congress & Expo

    Prague, Czech Republic
    November 11-12, 2019

    Annual Congress on Diabetes, Metabolism and Obesity

    Sydney, Australia
    Diabetes Congress 2019 | December 04-05, 2019 |

    3rd Annual Congress on Diabetes and Its Complications

    Tokyo, Japan
    December 12-13, 2019

    Annual Congress on Diabetes and Endocrinology

    Dubai, UAE
    January 29-30, 2020

    Global Summit On Diabetes & Endocrinology

    Bangkok, Thailand
    March 25-26, 2020

    29th World Diabetes & Heart Congress

    | Radisson Narita | Tokyo, Japan
    March 27-28, 2020

    Annual Summit on Metabolomics

    Amsterdam, Netherlands
    April 20-21, 2020

    2nd Global Meeting on Diabetes and Endocrinology

    Amsterdam, Netherlands
    June 14-15, 2021

    diabetic 2021

    Abu Dhabi, UAE

    Cardiovascular Endocrinology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in